New Insights From Leading Medical and Scientific Experts on the Science Behind Protandim

* Reuters is not responsible for the content in this press release.

Mon Aug 17, 2009 9:00am EDT

Montel Williams Interviews Top Experts in Recently Released Video on the Science
Behind LifeVantage`s Flagship Product, Protandim
SAN DIEGO--(Business Wire)--
LifeVantage Corporation (OTCBB:LFVN), a science-based, natural products company
dedicated to helping people reach their health and wellness goals through
science-based solutions for oxidative stress and the maker of Protandim,
announced today that it has added to its TrueTV online broadcast network a video
featuring a discussion between Montel Williams, LifeVantage Distributor and
celebrity talk show host, and two leading experts in the fields of science and
medicine, regarding the science behind LifeVantage`s indirect antioxidant
supplement, Protandim. Unlike traditional antioxidant therapies, Protandim is an
indirect antioxidant therapy, which means it works to stimulate the body`s
production of its own antioxidants. 

The interviewees were Dr. Joe McCord, a leading authority on the body`s
antioxidant defense system, developer of Protandim, and a member of the
Company`s Board of Directors, and Dr. David Perlmutter, an
internationally-recognized neurologist and member of the Company`s Scientific
Advisory Board, who has appeared on nationally-syndicated radio and television
programs including 20/20, Larry King Live, CNN, Fox News, The Today Show, Oprah,
Oprah Radio with Dr. Oz, and The CBS Early Show. 

"LifeVantage has an opportunity to really prove that its product, Protandim,
could be the breakthrough product that solves the antioxidant dilemma," stated
Montel Williams. "This is a product that withstood the peer-review test. It`s
backed by clinical trials, clinical studies, and thousands of years of science."


"What sold me is the science. The science is profound, it is sound, it is
cutting edge," added Dr. Perlmutter. "Protandim works in a totally unique way
from traditional antioxidant supplements, such as Vitamin C. Protandim speaks to
DNA, instructing your actual physiology to create an antioxidant supplement." 

According to Dr. McCord, the idea for Protandim came about as a result of 40
years of scientific research, beginning with the realization that free radicals
produce damaging cells, and further research was made possible by advances in
biochemical science in recent years. Protandim is a patented formula comprised
of all natural ingredients, studied and used for centuries in traditional
Chinese and Indian medicine. "The real secret to Protandim is the way the
ingredients work with each other in a process called synergy," stated Dr.
McCord. "Together, they are 18 times as effective as the sum of their parts.
That`s the real secret." 

The video is available for viewing on TrueTV at
http://www.lifevantage.com/truetv.aspx. 

About LifeVantage Corporation

LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based,
natural products company dedicated to helping people reach their health and
wellness goals through science-based solutions to oxidative stress. Founded in
2003 and based in San Diego, CA, LifeVantage develops nutraceutical products,
including Protandim®, that leverage the company's expertise and that are
intended to deliver significant health benefits to consumers. For more
information, visit www.LifeVantage.com. 

About Protandim

Protandim® is a clinically proven supplement that provides substantial benefits
to help with the challenges of healthy aging. This patented antioxidant therapy
works in a very different way than conventional foods such as red wine, oranges,
blueberries or other popular antioxidant supplements. Protandim® works by
increasing the body's natural antioxidant protection at the cellular level,
triggering (inducing) cells to produce naturally occurring protective
antioxidant enzymes such as superoxide dismutase (SOD), catalase, and
glutathione synthase. 

A peer-reviewed human clinical study showed that after Protandim® was taken for
30 consecutive days, the accumulation of lipid peroxidation products (a
biochemical marker of aging) was decreased by an average of 40%, although that
reduction may be not be typical for all those who consume the product. The study
also reported that this important marker of aging was decreased after taking
Protandim® to the level of a typical 20 year old. Protandim® is currently the
subject of approximately 20 scientific studies at leading universities and
research facilities. The nature and stages of the studies vary, as some of the
testing is at a preliminary stage, while other studies using Protandim® are
currently in progress. For more information about Protandim®, visit
www.LifeVantage.com. 

About LifeVantage TrueScience Anti-Aging Cream

LifeVantage TrueScience™ is scientifically-based and contains cutting-edge
ingredients, including those found in Protandim®. LifeVantage
TrueScience™Anti-Aging Cream gives skin a beautiful, even and smooth tone,
diminishes fine lines and wrinkles, and provides a vibrant and glowing
appearance. LifeVantage TrueScience™ also improves skin smoothness and
pigmentation, while increasing skin moisture. For more information about
LifeVantage TrueScience™, visit www.LifeVantage.com. 

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. Words
and expressions reflecting optimism, satisfaction or disappointment with current
prospects, as well as words such as "believe," "hopes," "intends," "estimates,"
"expects," "projects," "plans," "anticipates" and variations thereof, identify
forward-looking statements, but their absence does not mean that a statement is
not forward-looking. Such forward-looking statements are not guarantees of
performance and the Company`s actual results could differ materially from those
contained in such statements. These forward-looking statements are based on the
Company`s current expectations and beliefs concerning future events affecting
the Company and involve known and unknown risks and uncertainties that may cause
the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein. These risks and uncertainties include, among
others, the potential failure or unintended negative consequences of the
implementation of our network marketing sales channel; our ability to retain
independent distributors or to attract new independent distributors on an
ongoing basis; the potential for third party and governmental actions involving
our network marketing sales channel; the potential for product liability claims
against the Company; the risk that government regulators and regulations could
adversely affect our business; future laws or regulations may hinder or prohibit
the production or sale of our existing product and any future products;
unfavorable publicity could materially hurt our business; and the Company`s
ability to protect our intellectual property rights and the value of our
product. These and other risk factors are discussed in greater detail in the
Company`s Annual Report on Form 10-KSB and Quarterly Report on Form 10-Q under
the caption "Risk Factors", and in other documents filed by the Company from
time to time with the Securities and Exchange Commission. The Company cautions
investors not to place undue reliance on the forward-looking statements
contained in this document. All forward-looking statements are based on
information currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of this document,
except as required by law. 

*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease. 





LifeVantage Corporation
Ioana C. Hone, 858-312-8000 ext. 4 (Investors)
or
For LifeVantage Corporation
Jan Strode, 619-890-4040 (Media)
or
Jean Golden, 612-385-2324 (Media)

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.